Servier
Servier is the 2nd biggest French-based pharmaceutical company, present in 150 countries worldwide. It is managed by a non-profit foundation.
This “foundation” operating model makes us different because it gives us a high degree of independence and allows us to put patients’ interests at the centre of our activities, rather than shareholder or short-term financial interests.
That is why the Group invests 20% of its revenues in research and development.
Traditionally, Servier is invested and a worldwide market leader on hypertension, cardiology, diabetology and venous diseases, but recently the emphasis has shifted to include research in oncology and haematology with innovative targeted treatments to address high unmet medical needs.
Servier Bulgaria has been present in the market since 1993 and has built strong partnerships over those 30+ years with scientific leaders, healthcare providers and patient associations in its fields.
Servier is also dedicated to leaving a positive and sustainable impact on Society, find out more on our website www.servier.bg
